Document:

9%
      SERIES A CONVERTIBLE DEBENTURE

     

    THE
      DEBENTURE REPRESENTED BY THIS CERTIFICATE HAS NOT BEEN REGISTERED UNDER THE
      U.S.
      SECURITIES ACT OF 1933, AS AMENDED (“SECURITIES ACT”), AND MAY NOT BE SOLD,
      OFFERED FOR SALE, ASSIGNED, TRANSFERRED OR OTHERWISE DISPOSED OF TO ANY PERSON
      OR ENTITY WHO IS A CITIZEN, RESIDENT OR DOMICILIARY OF THE UNITED STATES OF
      AMERICA, ITS TERRITORIES OR POSSESSIONS, OR OF THE COMMONWEALTH OF PUERTO RICO,
      UNLESS REGISTERED PURSUANT TO THE PROVISIONS OF THAT ACT OR AN OPINION OF
      COUNSEL TO THE COMPANY IS OBTAINED STATING THAT SUCH DISPOSITION IS IN
      COMPLIANCE WITH AN AVAILABLE EXEMPTION FROM SUCH
      REGISTRATION.

     

    
      	
              $________________

            	
              July
                   , 2005

            

    

     

    
      	
              West
                Haven, Connecticut

            

    

     

    FOR
      VALUE RECEIVED,
      NanoViricides,
      Inc.,
      a
      Nevada corporation (the “Company”),
      promises to pay to the order of _____________
      or its
      registered assigns (the “Holder”),
      the
      principal sum of $______________ or such other amount as shall then equal the
      outstanding principal amount hereof, together with interest from the date of
      issuance of this Debenture on the unpaid principal balance hereof at a rate
      equal to nine percent (9%) per annum, computed on the basis of the actual number
      of days elapsed and a year of 365 days. All unpaid principal, together with
      any
      accrued but unpaid interest and other amounts payable hereunder, shall be due
      and payable on the earlier of (i) July __, 2006 (the “Maturity
      Date”),
      or
      (ii) when such amounts are declared due and payable by the Holder or made
      automatically due and payable upon or after the occurrence of an Event of
      Default (as defined below). Interest on this Debenture shall be payable
      quarterly, commencing on the ninetieth day from the issuance of this Debenture,
      in an amount of shares of the Company’s common stock, par value $.001 per share
      (the “Common Stock”), equal to the dollar amount of interest owed to the Holder,
      divided by the average closing price during the fifteen (15) prior trading
      days.
      Any payments of principal or interest shall be paid in United States
      Dollars.

     

    This
      Debenture is issued pursuant to the Subscription Agreement (the “Subscription
      Agreement”)
      dated
      as of July __, 2005 by and between the Company and the Holder. 

     

    The
      following is a statement of the rights of the Holder and the conditions to
      which
      this Debenture is subject, and to which the Holder hereof, by the acceptance
      of
      this Debenture, agrees:

    

      
        	 	
                (a)

              	
                “Business
                  Day”
                  means any day on which the national or state banks located in the
                  State of
                  New York are open to transact
                  business.

              

      

       

      
        	
              	(b)	
                “Conversion
                  Price”
                  has the meaning set forth in Section 5(a) hereof. 

              

      

       

      
        	 	
                (c)

              	
                “Obligations”
                  means the principal, interest and other amounts payable under this
                  Debenture.

              

      

       

      
        	
              	(d)	
                “Transaction
                  Documents”
                  shall mean this Debenture and the Subscription Agreement. 

              

      

    

     

    2.         Events
      of Default.
      The
      occurrence of any of the following shall constitute an “Event
      of Default”
under
      this Debenture:

     

    
      
         

      

      
         

        
          

        

      

      
         

      

    

    

     

    (a)        Failure
      to Pay.
      The
      Company shall fail to pay (i) when due any principal payment on this
      Debenture or (ii) any interest or other payment required under the terms of
      this Debenture or any other Transaction Document within five (5) Business Days
      of its due date; or

     

    (b)        Breaches
      of Other Covenants.
      The
      Company shall fail to observe or to perform any other covenant, obligation,
      condition or agreement contained in this Debenture or the other Transaction
      Documents, other than those specified in Section 2(a) hereof, and such
      failure shall continue for thirty (30) days; or 

     

    (c)        Voluntary
      Bankruptcy or Insolvency Proceedings.
      The
      Company shall (i) apply for or consent to the appointment of a receiver,
      trustee, liquidator or custodian of itself or of all or a substantial part
      of
      its property, (ii) be unable, or admit in writing its inability, to pay its
      debts generally as they mature, (iii) make a general assignment for the
      benefit of its or any of its creditors, (iv) be dissolved or liquidated in
      full or in part, (v) become insolvent (as such term may be defined or
      interpreted under any applicable statute), (vi) commence a voluntary case
      or other proceeding seeking liquidation, reorganization or other relief with
      respect to itself or its debts under any bankruptcy, insolvency or other similar
      law now or hereafter in effect or consent to any such relief or to the
      appointment of or taking possession of its property by any official in an
      involuntary case or other proceeding commenced against it or (vii) take any
      action for the purpose of effecting any of the foregoing; or

     

    (d)        Involuntary
      Bankruptcy or Insolvency Proceedings.
      Proceedings for the appointment of a receiver, trustee, liquidator or custodian
      of the Company or of all or a substantial part of the property thereof, or
      an
      involuntary case or other proceedings seeking liquidation, reorganization or
      other relief with respect to the Company or the debts thereof under any
      bankruptcy, insolvency or other similar law now or hereafter in effect shall
      be
      commenced and an order for relief entered, or such case or proceeding shall
      not
      be dismissed or discharged within forty-five (45) days of commencement.

     

    3.         Rights
      of Holder Upon Default.
      Upon
      the occurrence or existence of any Event of Default (other than an Event of
      Default referred to in Sections 2(c) and 2(d) hereof) and at any time
      thereafter during the continuance of such Event of Default, the Holder may
      declare all outstanding Obligations payable by the Company hereunder to be
      immediately due and payable without presentment, demand, protest or any other
      notice of any kind, all of which are hereby expressly waived, anything contained
      herein or in the other Transaction Documents to the contrary notwithstanding.
      Upon the occurrence or existence of any Event of Default described in
      Sections 2(c) and 2(d) hereof, immediately and without notice, all
      outstanding Obligations payable by the Company hereunder shall automatically
      become immediately due and payable, without presentment, demand, protest or
      any
      other notice of any kind, all of which are hereby expressly waived, anything
      contained herein or in the other Transaction Documents to the contrary
      notwithstanding. In addition to the foregoing remedies, upon the occurrence
      or
      existence of any Event of Default, the Holder may exercise any other right,
      power or remedy granted to it by the Transaction Documents or otherwise
      permitted to it by law, either by suit in equity or by action at law, or both.
      

     

    4.         Prepayment.
      This
      Debenture may not be prepaid except as set forth in Section 7 herein.

     

    5. Conversion.

    

    (a)        Conversion
      by the Holder.
      The
      Holder, at its option and so long as the Company has a sufficient number of
      shares reserved and available for issuance, may convert all, but not less than
      all, of the sum of the principal then outstanding on the Debenture at the
      Maturity Date into a number of shares of Common Stock equal the outstanding
      principal balance, divided by seventy percent (70%) of the average closing
      price
      of the Common Stock during the fifteen (15) trading days preceding the Maturity
      Date (the “Conversion Price”). The Conversion Price shall not exceed $0.50,
      subject to adjustment as set forth in Section 6 herein.

     

    
      
         

      

      
        -2-

        
          

        

      

      
         

      

    

    

     

    (b)        Mechanics
      and Effect of Conversion.
      No
      fractional shares of Common Stock shall be issued upon conversion of this
      Debenture. Upon the conversion of all of the principal outstanding under this
      Debenture, in lieu of the Company issuing any fractional shares to the Holder,
      the Company shall round all shares to the next whole share. Upon conversion
      of
      this Debenture pursuant to this Section, the Holder shall surrender this
      Debenture, duly endorsed, at the principal office of the Company. At its
      expense, the Company shall, as soon as practicable thereafter, issue and deliver
      to such Holder at such principal office a certificate or certificates for the
      number of shares of such Common Stock to which the Holder shall be entitled
      upon
      such conversion (bearing such legends as are required by the Subscription
      Agreement and applicable state and federal securities laws in the opinion of
      counsel to Company), together with any other securities and property to which
      the Holder is entitled upon such conversion under the terms of this Debenture.
      Upon full conversion of this Debenture, Company shall be forever released from
      all its obligations and liabilities under this Debenture.

     

    (c)        Reservation
      of Stock Issuable Upon Conversion.
      The
      Company shall at all times, reserve and keep available out of its authorized
      but
      unissued shares of Common Stock, solely for the purpose of effecting the
      conversion of this Debenture, such number of its shares of Common Stock as
      shall
      from time to time be sufficient to effect the conversion of this Debenture;
      and
      if at any time the number of authorized but unissued shares of Common Stock
      shall not be sufficient to effect the conversion of this Debenture, the Company
      will take such corporate action as may, in the opinion of its counsel, be
      necessary to increase its authorized but unissued shares of Common Stock to
      such
      number of shares as shall be sufficient for such purpose.

     

    (d)        Payment
      of Taxes.
      The
      Company will pay all transfer taxes or charges that may be imposed with respect
      to the issue or delivery of shares of Common Stock upon conversion of this
      Debenture, except for any tax or other charge imposed in connection with any
      transfer involved in the issue and delivery of shares of Common Stock in a
      name
      other than that in which this Debenture was registered.

     

    6. Conversion
      Price Adjustments.

    

    (a)        Adjustment
      for Stock Splits and Combinations.
      If the
      Company shall at any time or from time to time after date of first issuance
      of
      this Debenture (the “Date
      of Original Issue”)
      effect
      a stock split or subdivision of the outstanding Common Stock, the Conversion
      Price in effect immediately before that subdivision shall be proportionately
      decreased, and, conversely, if the Company shall at any time or from time to
      time after the Date of Original Issue combine the outstanding shares of Common
      Stock into a smaller number of shares, the Conversion Price in effect
      immediately before the combination shall be proportionately increased. Any
      adjustment under this Section 6(a) shall become effective at the close of
      business on the date the stock split, subdivision or combination becomes
      effective.

     

    (b)        Dividends
      and Distributions.
      The
      Company at any time or from time to time after the Date of Original Issue to
      the
      Maturity Date shall not issue a dividend or other distribution payable in
      securities of the Company or other property. As used herein, the term “other
      property” does not include cash.

     

    (c)        Adjustment
      for Reclassification, Exchange and Substitution.
      If at
      any time or from time to time after the Date of Original Issue, the Common
      Stock
      issuable upon the conversion of this Debenture is changed into the same or
      a
      different number of shares of any class or series of stock, whether by
      recapitalization, reclassification or otherwise (other than a subdivision or
      combination of shares or stock dividend or a reorganization, merger,
      consolidation or sale of assets provided for elsewhere in this Section 6),
      then in any such event the Holder shall have the right thereafter to convert
      this Debenture into the kind and amount of stock and other securities and
      property receivable upon such recapitalization, reclassification or other change
      by holders of the number of shares of Common Stock into which this Debenture
      could have been converted immediately prior to such recapitalization,
      reclassification or change, all subject to further adjustment as provided herein
      or with respect to such other securities or property by the terms
      thereof.

     

    
      
         

      

      
        -3-

        
          

        

      

      
         

      

    

    

     

    (d)        Reorganizations.
      If at
      any time or from time to time after the Date of Original Issue there is a
      capital reorganization of the Common Stock (other than a recapitalization,
      subdivision, combination, reclassification, exchange or substitution of shares
      provided for elsewhere in this Section 6), as a part of such capital
      reorganization provision shall be made so that the Holder shall thereafter
      be
      entitled to receive upon conversion of this Debenture the number of shares
      of
      stock or other securities or property of the Company to which a holder of the
      number of shares of Common Stock deliverable upon such conversion would have
      been entitled on such capital reorganization, subject to adjustment in respect
      of such stock or securities by the terms thereof. In any such case, appropriate
      adjustment shall be made in the application of the provisions of this
      Section 6 with respect to the rights of the Holders after such capital
      reorganization to the end that the provisions of this Section 6 (including
      adjustment of the Conversion Price then in effect and the number of shares
      issuable upon conversion of this Debenture) shall be applicable after that
      event
      and be as nearly equivalent as practicable.

     

    (e)         No
      Impairment.
      The
      Company shall not amend its Certificate of Incorporation or participate in
      any
      reorganization, transfer of assets, consolidation, merger, dissolution, issue
      or
      sale of securities or any other voluntary action for the purpose of avoiding
      or
      seeking to avoid the observance or performance of any of the terms to be
      observed or performed hereunder by the Company, but shall at all times in good
      faith assist in carrying out all such action as may be reasonably necessary
      or
      appropriate in order to protect the conversion rights of the Holders of this
      Debenture against dilution or other impairment as provided herein.

     

    7.         Redemption.

     

    (a) Redemption
      by the Company.
      The
      Company, at its sole option, shall have the right, but not the obligation,
      to
      repurchase the Debenture if at the Maturity Date, the average closing price
      of
      the Common Stock for the five (5) days preceding the Maturity Date is below
      $0.25, subject to adjustment as set forth in Section 6 herein (the
“Redemption”). Upon Redemption, the Company shall pay to the Holder, the
      principal amount of the Debenture with interest at the rate of fifteen percent
      (15%) per annum (the “Redemption Payment”).

     

    (b) Mechanics
      of Redemption.
      Any
      amounts paid to the Holder pursuant to the Redemption shall be paid in
      immediately available funds to the order of the Holder or its assigns.
      Notwithstanding the receipt by the Company of the Holder’s Conversion Notice,
      the Company shall still have the right to redeem the debenture as set forth
      in
      subsection(a) above. The Company shall deliver the Redemption Payment to the
      Holder at the Holder’s address set forth herein and the Company shall be forever
      released from all its obligations and liabilities under this
      Debenture.

     

    8.         
      Successors
      and Assigns.
      Subject
      to the restrictions on transfer described in Sections 10 and 11
      hereof, the rights and obligations of the Company and the Holder of this
      Debenture shall be binding upon and benefit the successors, assigns, heirs,
      administrators and transferees of the parties.

     

    9.         Waiver
      and Amendment.
      Any
      provision of this Debenture may be amended, waived or modified only as to the
      Holder of this Debenture upon the written consent of the Company and the
      Holder.

     

    10.         Transfer
      of this Debenture or Securities Issuable on Conversion Hereof.
      This
      Debenture may not be transferred in violation of any restrictive legend set
      forth hereon. Each new Debenture issued upon transfer of this Debenture shall
      bear a legend as to the applicable restrictions on transferability in order
      to
      ensure compliance with the Securities Act, unless in the opinion of counsel
      for
      the Company such legend is not required in order to ensure compliance with
      the
      Securities Act. The Company may issue stop transfer instructions to its transfer
      agent in connection with such restrictions. Subject to the foregoing, transfers
      of this Debenture shall be registered upon registration books maintained for
      such purpose by or on behalf of the Company. Prior to presentation of this
      Debenture for registration of transfer, the Company shall treat the registered
      holder hereof as the owner and holder of this Debenture for the purpose of
      receiving all payments of principal and interest hereon and for all other
      purposes whatsoever, whether or not this Debenture shall be overdue and the
      Company shall not be affected by notice to the contrary.

     

    
      
         

      

      
        -4-

        
          

        

      

      
         

      

    

    

     

    11.       Assignment
      by the Company.
      Neither
      this Debenture nor any of the rights, interests or obligations hereunder may
      be
      assigned, by operation of law or otherwise, in whole or in part, by the Company,
      without the prior written consent of the Holder.

     

    12.       Notices.
      Any
      notice, request or other communication required or permitted hereunder shall
      be
      in writing and shall be deemed to have been duly given if personally delivered
      or mailed by registered or certified mail, postage prepaid, or by recognized
      overnight courier, personal delivery or facsimile transmission at the respective
      addresses or facsimile number of the parties as set forth in the Subscription
      Agreement or on the register maintained by the Company. Any party hereto may
      by
      notice so given change its address or facsimile number for future notice
      hereunder. Notice shall conclusively be deemed to have been given when
      received.

     

    13.       Expenses;
      Waivers.
      If
      action is instituted to collect this Debenture, the Company promises to pay
      all
      costs and expenses, including, without limitation, reasonable attorneys’ fees
      and costs, incurred in connection with such action. The Company hereby waives
      notice of default, presentment or demand for payment, protest or notice of
      nonpayment or dishonor and all other notices or demands relative to this
      instrument.

     

    14.       Governing
      Law.
      This
      Debenture and all actions arising out of or in connection with this Debenture
      shall be governed by and construed in accordance with the laws of the State
      of
      Nevada, without regard to conflict of laws provisions thereof. In the event
      of
      any dispute among or between any of the parties to this Debenture arising out
      of
      the terms of this Debenture, the parties hereby consent to the exclusive
      jurisdiction of the federal and state courts located in the State of New York
      for resolution of such dispute, and agree not to contest such exclusive
      jurisdiction or seek to transfer any action relating to such dispute to any
      other jurisdiction.

     

    IN
      WITNESS WHEREOF,
      the
      Company has caused this Debenture to be issued as of the date first written
      above.

    
      	 	 	 
	 	NANOVIRICIDES,
              INC.
	 
 	 
 	 
 
	 	By:  	 
	 	
              
Anil
              Diwan, President
	 	 

    

     

     

    
      
         

      

      
        -5-THIS
      WARRANT AND THE SHARES OF COMMON STOCK ISSUABLE UPON EXERCISE OF THIS WARRANT
      HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR ANY
      STATE SECURITIES LAWS. THIS WARRANT AND THE COMMON STOCK ISSUABLE UPON EXERCISE
      OF THIS WARRANT MAY NOT BE SOLD, OFFERED FOR SALE, PLEDGED OR HYPOTHECATED
      IN
      THE ABSENCE OF AN EFFECTIVE REGISTRATION STATEMENT AS TO THIS WARRANT UNDER
      SAID
      ACT AND ANY APPLICABLE STATE SECURITIES LAWS OR AN OPINION OF COUNSEL REASONABLY
      SATISFACTORY TO CERTIFIED SERVICES, INC. THAT SUCH REGISTRATION IS NOT
      REQUIRED.

     

    

    COMMON
      STOCK PURCHASE WARRANT
      

    

    Right
      to
      Purchase 100,000 Shares of Common Stock of

    

    NanoViricides,
      Inc.

    

     

    NanoViricides,
      Inc., a corporation organized under the laws of the State of Nevada (the
“Corporation”) hereby certifies that, for value received, ___________ or its
      successors or assigns (the “Holder”) is entitled to purchase from the
      Corporation upon the due exercise hereof, and subject to the terms and
      conditions herein, from the date of issue of this warrant (the “Warrant”) until
      July 31, 2006 (the "Expiration Date"), all or any part of 100,000 fully paid
      and
      non-assessable shares of common stock, par value $.001 per share (the "Common
      Stock") of the Corporation, upon surrender hereof, with the exercise form
      annexed hereto duly completed and executed, at the office of the Corporation
      and
      upon simultaneous payment therefore in cash or by certified or official bank
      check, payable to the order of the Corporation, at a price per share of $.25
      (the "Exercise Price") subject to adjustment as provided herein. 

    

    1. Restriction
      on Transfer. No
      resale
      of the Warrant or of any of the shares of Common Stock underlying the exercise
      of the Warrant (the “Underlying Stock”) will be made unless such resale is
      registered pursuant to a registration statement filed by the Corporation with
      the Securities and Exchange Commission (the "Commission") or an exemption from
      registration under the Securities Act of 1933, as amended (the "Act"). By
      acceptance of this agreement, the Holder agrees, for itself and all subsequent
      holders, that prior to making any disposition of the Warrant or of any
      Underlying Stock, the Holder shall give written notice to the Corporation
      describing briefly the proposed disposition; and no such disposition shall
      be
      made unless and until ( i ) the Corporation has notified the Holder that, in
      the
      opinion of counsel satisfactory to it, no registration or other action under
      the
      Act is required with respect to such disposition (which opinion may be
      conditioned upon the transferee's assuming the Holder's obligation hereunder);
      or (ii) a registration statement under the Act has been filed by the Corporation
      and declared effective by the Commission or other such similar action has been
      taken. 

    
      
         

      

      
        Page
          1 of 5

        
          

        

      

      
         

      

    

    

    

    2. Expiration
      of Warrant.
      Unless
      this Warrant and the Exercise price are tendered as herein provided before
      the
      close of business on the Expiration Date, this Warrant will become wholly void
      and all rights and obligations set forth herein shall expire and
      terminate.

    

    3. Partial
      Exercise.
      If this
      Warrant is exercised for less than all the shares purchasable upon the exercise
      hereof, the Warrant shall be surrendered by the Holder and replaced with a
      new
      warrant of like tender in the name of the Holder providing for the right to
      purchase the number of shares of Underlying Stock as to which this Warrant
      has
      not yet been exercised.

    

    4. Adjustments.
      The
      Exercise Price and the number of shares of Underlying Stock of the Corporation
      issuable pursuant to such exercise is subject to adjustment as
      follows:

    

    (a) In
      case
      the Corporation shall at any time declare a stock dividend or stock split on
      the
      outstanding shares of Common Stock in shares of its Common Stock, then the
      Exercise Price and number of shares of Underlying Stock shall be proportionately
      adjusted so that the holder of any Warrant exercised after such time shall
      be
      entitled to receive the aggregate number and kind of shares which if such
      Warrant had been exercised immediately prior to such time, he or she would
      have
      owned upon such exercise and been entitled to receive by virtue of such
      dividend.

    

    (b) In
      any
      case the Corporation shall at any time subdivide or combine the outstanding
      shares of the Common Stock, the Exercise Price, initial or adjusted, in effect
      immediately prior to such subdivision or combination shall forthwith be
      proportionately decreased in the case of subdivision or increased in the case
      of
      combination.

    

    (c) In
      case
      of any capital reorganization, sale of substantially all the assets of the
      Corporation, or any reclassification of the shares of Common Stock of the
      Corporation, or in case of any consolidation with or merger of the Corporation
      into or with another corporation, then as a part of such reorganization sale
      reclassification, consolidation or merger, as the case may be, provision shall
      be made so that the registered owner of the Warrant evidenced hereby shall
      have
      the right thereafter to receive upon the exercise thereof the kind and amount
      of
      shares of stock or other securities or property which he would have been
      entitled to receive if immediately prior to such reorganization,
      reclassification, consolidation or merger, he had held the number of shares
      of
      Underlying Stock which were then issuable upon the exercise of the Warrant
      evidenced hereby, to the end that the provisions set forth (including provisions
      with respect to adjustments of the Exercise Price) shall thereafter be
      applicable, as nearly as reasonably may be, in relation to any shares of stock
      or other property thereafter deliverable upon the exercise of such Warrants.
      

    
      
         

      

      
        Page
          2 of 5

        
          

        

      

      
         

      

    

    

    

    (d) If
      the
      Corporation at any time makes any spin-off, split-off, or distribution of assets
      upon or with respect to its Common Stock, as a liquidating or partial
      liquidating dividend, spin-off, or by way of return of capital, or other than
      as
      dividend payable out of earnings or any surplus legally available for dividends
      under the laws of the State of Nevada, the holder of each Warrant then
      outstanding shall, upon the exercise of the Warrant, receive, in addition to
      the
      shares of Common Stock then issuable on exercise of the Warrant, the amount
      of
      such assets (or, at the option of the Corporation, a sum equal to the value
      thereof at the time of the distributions) which would have been payable to
      such
      holder had he or she exercised the Warrant immediately prior to the record
      date
      for such distribution.

    

    (e) When
      any
      adjustment is required to be made to the Exercise Price, the number of shares
      of
      Common Stock issuable shall be determined as provided for in paragraph (f)
      hereof. No fractional shares of Common Stock shall be issued upon the exercise
      of the Warrant. The Corporation shall round all fractional shares to the next
      whole share. 

    

    (f) Whenever
      the Exercise Price is adjusted as provided above, the number of shares of
      Underlying Stock immediately prior to such adjustment shall be increased,
      effective simultaneously with such adjustment, by a number of shares of Common
      Stock computed by multiplying such number of shares of Common Stock by a
      fraction, the numerator of which is the Exercise Price in effect immediately
      prior to such adjustment and the denominator of which is the Exercise Price
      in
      effect upon such adjustment, and the number of shares of Underlying Stock
      arrived at by making said computation shall be added to the number of shares
      of
      Underlying Stock immediately prior to such adjustment. The total number of
      shares arrived at by making the computation provided for in the immediately
      preceding sentence shall thereupon be the number of shares of Common Stock
      issuable upon exercise or the Warrant and the Corporation shall forthwith
      determine the new Exercise Price, and (a) prepare a statement describing in
      reasonable detail the method used in arriving at the new Exercise Price; and
      (b)
      cause a copy of such statement to be mailed to the Holder within twenty (20)
      days after the date when the circumstance giving rise to the adjustments
      occurred. 

    

    5. Delivery
      of Underlying Stock.
      As soon
      as practicable after the exercise hereof, the Corporation shall deliver a
      certificate or certificates for the number of full shares of Underlying Stock,
      all of which shall be fully paid and nonassessable, to the person or persons
      entitled to receive the same provided no sale, offer to sell or transfer of
      the
      Underlying Stock or of this Warrant, or of any shares or other securities issued
      in exchange for or in respect of such shares, shall be made unless a
      registration statement under the Act, with respect to such shares, is in effect
      or an exemption from the registration requirements of such Act is applicable
      to
      such shares.

    
      
         

      

      
        Page
          3 of 5

        
          

        

      

      
         

      

    

    

    

    6. Miscellaneous.
      This
      Warrant and any term hereof may be changed, waived, discharged or terminated
      only by an instrument in writing signed by the party against which enforcement
      of such change, waiver, discharge or termination is sought. This Warrant shall
      be governed by and construed in accordance with the laws of State of Nevada
      without regard to principles of conflicts of laws. Any action brought concerning
      the transactions contemplated by this Warrant shall be brought only in the
      state
      courts of New York or in the federal courts located in the state of New York;
      provided, however, that the Corporation may choose to waive this provision
      and
      bring an action outside the state of New York. The individuals executing this
      Warrant on behalf of the Corporation agree to submit to the jurisdiction of
      such
      courts and waive trial by jury. In the event that any provision of this Warrant
      is invalid or unenforceable under any applicable statute or rule of law, then
      such provision shall be deemed inoperative to the extent that it may conflict
      therewith and shall be deemed modified to conform with such statute or rule
      of
      law. Any such provision which may prove invalid or unenforceable under any
      law
      shall not affect the validity or enforceability of any other provision of this
      Warrant. The headings in this Warrant are for purposes of reference only, and
      shall not limit or otherwise affect any of the terms hereof. The invalidity
      or
      unenforceability of any provision hereof shall in no way affect the validity
      or
      enforceability of any other provision.

     

    

    Dated: July
      ____, 2005

    

    NANOVIRICIDES,
      INC.

    

    

    By:
      __________________

    Name:
      

    Title"

    

    

    Warrant
      Holder: _______________________________________

    

    Address:
      _____________________________________________

    

    City:
      ________________________________________________

    

    State:
      _____________________________ Zip Code: _________

    

    

    
      
         

      

      
        Page
          4 of 5

        
          

        

      

      
         

      

    

    

    

    EXERCISE
      FORM

    

    

    The
      undersigned irrevocably exercises this Warrant to the extent of
      ____________shares of the Common Stock of NanoViricides, Inc., called for
      hereby, and hereby makes payment thereof, all at the price and on the terms
      and
      conditions specified herein.

    

    ___________________________

                  SIGNATURE

    

    Name:
      _______________________________________

    

    Address:
      _____________________________________

    

    City:
      ________________________________________

    

    State:
      ________________________Zip Code: _______

    

    Date: _____________,
      200_

    

    

    
      

      
        
           

        

        
          Page
            5 of 5

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00113-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00113-of-00352.parquet"}]]